Brand name authorized in: South Africa
The drug ABEXEM contains one active pharmaceutical ingredient (API):
Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: